T. Rowe Price Associates’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2M | Buy |
1,322,439
+266,677
| +25% | +$15.4M | 0.01% | 627 |
|
|
2025
Q1 | $61.5M | Buy |
1,055,762
+341,906
| +48% | +$19.9M | 0.01% | 661 |
|
|
2024
Q4 | $57.5M | Sell |
713,856
-63,574
| -8% | -$5.12M | 0.01% | 714 |
|
|
2024
Q3 | $62.3M | Sell |
777,430
-391,872
| -34% | -$31.4M | 0.01% | 696 |
|
|
2024
Q2 | $71.4M | Sell |
1,169,302
-298,357
| -20% | -$18.2M | 0.01% | 615 |
|
|
2024
Q1 | $72.5M | Sell |
1,467,659
-38,000
| -3% | -$1.88M | 0.01% | 620 |
|
|
2023
Q4 | $63.1M | Sell |
1,505,659
-250,844
| -14% | -$10.5M | 0.01% | 634 |
|
|
2023
Q3 | $57.6M | Buy |
1,756,503
+225,163
| +15% | +$7.39M | 0.01% | 639 |
|
|
2023
Q2 | $54.1M | Buy |
1,531,340
+187,575
| +14% | +$6.63M | 0.01% | 679 |
|
|
2023
Q1 | $38.2M | Buy |
1,343,765
+175,148
| +15% | +$4.97M | 0.01% | 755 |
|
|
2022
Q4 | $48.5M | Buy |
1,168,617
+97,383
| +9% | +$4.05M | 0.01% | 668 |
|
|
2022
Q3 | $44.4M | Sell |
1,071,234
-2,832,769
| -73% | -$117M | 0.01% | 682 |
|
|
2022
Q2 | $128M | Buy |
3,904,003
+58,511
| +2% | +$1.91M | 0.02% | 592 |
|
|
2022
Q1 | $135M | Buy |
3,845,492
+2,442,421
| +174% | +$85.5M | 0.01% | 639 |
|
|
2021
Q4 | $34.1M | Buy |
1,403,071
+62,087
| +5% | +$1.51M | ﹤0.01% | 1133 |
|
|
2021
Q3 | $49.7M | Buy |
+1,340,984
| New | +$49.7M | ﹤0.01% | 1013 |
|